You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

MENADIONE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for menadione and what is the scope of patent protection?

Menadione is the generic ingredient in one branded drug marketed by Lilly and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for menadione.

Summary for MENADIONE
Recent Clinical Trials for MENADIONE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Scotmann PharmaceuticalsPhase 3
University of Health Sciences LahorePhase 3
Tanta UniversityPhase 1

See all MENADIONE clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for MENADIONE

US Patents and Regulatory Information for MENADIONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly MENADIONE menadione TABLET;ORAL 002139-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

MENADIONE Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Menadione (Vitamin K3)

Introduction to Menadione (Vitamin K3)

Menadione, also known as Vitamin K3, is an organic compound that plays a crucial role as a nutritional supplement. It is widely used in various industries, including animal feed, pharmaceuticals, and food. Here, we will delve into the market dynamics and financial trajectory of Menadione.

Market Size and Forecast

The global Menadione market is projected to experience steady growth over the coming years. According to market research, the vitamin K3 menadione market is expected to increase at a Compound Annual Growth Rate (CAGR) of 3 to 5 percent from its estimated valuation by 2031[1].

Segmentation of the Market

The Menadione market is segmented based on several key factors:

By Application

  • Feed Industry: Menadione is widely used in animal feed to ensure the health and well-being of livestock.
  • Pharmaceutical Industry: It is used in various pharmaceutical products, including those for human health and veterinary care.
  • Food Industry: Menadione is also utilized in the food industry, particularly in the production of fortified foods[1][4].

By Product Grade

  • Feed Grade: Used in animal feed.
  • Pharmaceutical Grade: Used in the production of medicines.
  • Food Grade: Used in the food industry for human consumption[1][4].

By Geography

The market is analyzed across various geographical regions, including North America, Europe, Asia-Pacific, South America, and the Middle East and Africa[1][4].

Key Market Players

The Menadione market is dominated by several key players, including:

  • Dirox
  • Oxyvit
  • Brother Enterprises
  • Mianyang Vanetta Chemical
  • Haining Peace Chemical
  • Huasheng Chemical Technology
  • Zhenhua Chemical
  • Chongqing Minfeng Chemical[1][2][4].

Drivers of Market Growth

Several factors are driving the growth of the Menadione market:

Increasing Awareness of Vitamin Supplements

There is a growing awareness about the importance of vitamin supplements, which is expected to drive the demand for Menadione. This awareness is particularly high in regions where vitamin deficiency disorders are prevalent[4].

Technological Advancements

Advancements in vitamin delivery systems are expected to boost the market growth. New technologies make it easier and more efficient to incorporate Menadione into various products[4].

Use in Animal Feed

The use of Menadione in animal feed is significant, and the growing demand for healthy livestock is driving this segment of the market[1][2].

Challenges and Restraints

Despite the growth drivers, the Menadione market faces several challenges:

Low Product Penetration in Developing Countries

Menadione has low penetration in developing countries, which hampers market growth. This is due to limited awareness and lower economic capabilities in these regions[4].

Strict Regulatory Frameworks

Strict regulations set by regulatory authorities such as the FDA can impede market growth. Compliance with these regulations can be costly and time-consuming for manufacturers[4].

Financial Trajectory

The financial trajectory of the Menadione market is positive, with steady growth anticipated:

Revenue Forecast

The market is expected to grow from its current valuation to reach a significant figure by 2031, driven by the increasing demand in various application segments[1].

Regional Performance

North America and Europe are expected to be key regions driving the market growth, followed by the Asia-Pacific region, which is anticipated to show significant growth due to increasing demand and technological advancements[1][4].

Competitive Landscape

The competitive landscape of the Menadione market is highly competitive, with several major players vying for market share. These companies are focusing on product innovation, strategic partnerships, and expanding their geographical presence to stay ahead in the market.

Future Outlook

The future outlook for the Menadione market is promising, driven by the increasing demand for vitamin supplements and the growing awareness of health benefits associated with Vitamin K3.

"Surge in prevalence of various vitamin deficiency disorders and increase in awareness regarding vitamin supplements is expected to drive the vitamin K3 market."[4]

Illustrative Statistics

  • The global Menadione market is expected to grow at a CAGR of 3 to 5 percent from 2024 to 2031[1].
  • The North American market for Menadione is estimated to increase significantly by 2030[2].
  • Technological advancements in vitamin delivery systems are expected to boost the market growth[4].

Quotes from Industry Experts

Industry experts highlight the importance of Menadione in various industries:

"Menadione is a critical component in animal feed, ensuring the health and well-being of livestock. Its use is expected to continue growing as the demand for healthy livestock increases," said a spokesperson from Dirox[2].

Key Takeaways

  • The Menadione market is expected to grow at a CAGR of 3 to 5 percent from 2024 to 2031.
  • The market is segmented by application, product grade, and geography.
  • Key drivers include increasing awareness of vitamin supplements and technological advancements.
  • Challenges include low product penetration in developing countries and strict regulatory frameworks.
  • The competitive landscape is highly competitive with several major players.

FAQs

Q: What are the primary applications of Menadione? A: Menadione is primarily used in the feed industry, pharmaceutical industry, and food industry.

Q: Who are the key players in the Menadione market? A: Key players include Dirox, Oxyvit, Brother Enterprises, Mianyang Vanetta Chemical, and others.

Q: What are the main drivers of the Menadione market growth? A: The main drivers include increasing awareness of vitamin supplements and technological advancements in vitamin delivery systems.

Q: What are the challenges faced by the Menadione market? A: Challenges include low product penetration in developing countries and strict regulatory frameworks.

Q: What is the expected CAGR of the Menadione market from 2024 to 2031? A: The market is expected to grow at a CAGR of 3 to 5 percent from 2024 to 2031.

Sources

  1. Market Research Intellect - Global Vitamin K3 Menadione Market Size and Forecast[1]
  2. Valuates Reports - Global Menadione (Vitamin K3) Market Research Report 2024[2]
  3. Allied Market Research - Vitamin K3 Market[4]
  4. Market Research Store - Vitamin K3 (Menadione) Market - Global Industry Research Analysis[5]

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.